Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2015 Q2- Text added to 2015 Q3
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. sophomore Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. sophomore Avg
|
New words:
adenocarcinoma, advisor, al, anorectal, apparent, Aug, axalimogene, bladder, Bono, brain, brought, Canada, canal, category, Ch, Chancery, chemo, China, Cigarette, cohort, conform, DCGI, Del, Delaware, disgorgement, driven, durvalumab, duty, enrichment, Europe, face, failed, fiduciary, filolisbac, forgoing, Governor, healthcare, Histologically, Homeland, Honorable, Indian, induction, injunctive, innovative, insight, interaction, KCM, Knight, Knoll, lapse, large, Larkin, low, MAA, mainland, member, NSCLC, Obstetrical, opportunity, ourLm, ovarian, pancreatic, permit, pharmaceutical, prescription, prevalence, proceeding, proof, proportionate, reclassified, relief, Ridge, Sectoral, security, shareholder, shortly, slight, smoked, smoking, specialty, stand, stockholder, straight, styled, successor, Timothy, Tom, unjust, unspecified, variety, violation, vitroeffect, waste
Valuein 2015 Q2 filing- Value in 2015 Q3 filing
Original filings
Filing view